Amneal Pharmaceutical Recalls Medication (SNF/AL)

The FDA also posted a recall notice for Amneal Pharmaceutical LLC Sulfamethoxazole/Trimethoprim Tablets, USP, 400 mg/80 mg only. The company is recalling three lots of these tablets, distributed nationwide to wholesalers/distributors between December 4, 2024, and May 15, 2025, as they may exhibit black spots on the tablet surface due to microbial contamination. Oral products contaminated with Aspergillus may result in serious and life-threatening infections. For medical inquiries or to report adverse events or quality problems, contact Amneal Drug Safety by phone at (877) 835-5472 or email.